Longeveron Inc. held a Type C meeting with the U.
Author: Michael
Alterity Therapeutics will deliver three presenta
Rznomics announced that the U.S.
Ahead of The Longevity Show, Steve Horvath expla
Neuraly-backed study explores whether a long-act
Voyager’s latest preclinical results suggest b
AI imaging expanded to routine scans, turning ev
Global teams gain funding and data access to ide
Diathrive Health and AliveCor’s KardiaComplete
Neuvasq presented preclinical data at the ARVO 20